| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 375000.0 | 500000.0 | 2635094.0 |
| Other income | 0.0 | 0.0 | 676.0 |
| Total income | 375000.0 | 500000.0 | 2635770.0 |
| Profit before exceptional items & tax | 15624.0 | 105206.0 | 18548.0 |
| Profit before tax | 15624.0 | 105206.0 | 18548.0 |
| Net profit | -81745.0 | 105206.0 | -834895.0 |
| Operating margin | 4.2% | 21.0% | 0.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -85.80% |
|---|
Source
Read the filing ↗
BSE results filing, NSE: GVBL. Figures extracted from the filing.
Genomic Valley Biotech Ltd: key numbers
- Share price
- ₹27.65
- Market cap
- ₹8.45 Cr
- Revenue (annual)
- ₹0.27 Cr
- Net profit (annual)
- ₹0.03 Cr
- P/E (TTM)
- 415.2×Sector 50.4×
- Promoter holding
- 46.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genomic Valley Biotech Ltd
All →
16:00 IST
BSE
Financial Results
Genomic Valley Biotech Q1 FY27 Results: Net Profit ₹146,162 Cr, Down 40.7% YoY
Genomic Valley Biotech Ltd reported revenue from operations of ₹380,000 Cr (-57.8% YoY) and net profit of ₹146,162 Cr (-40.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹146,162 Cr · -40.7% YoY